Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Mol Oncol ; 12(8): 1374-1382, 2018 08.
Article in English | MEDLINE | ID: mdl-29873181

ABSTRACT

Recently, we have developed a diphtheria toxin-based recombinant anti-human CCR4 immunotoxin for targeting CCR4+ tumors and Tregs. In this study, we further optimized the dosing schedule for improved CCR4+ Treg depletion. We have demonstrated that up to a 90% depletion was achieved and the depletion extended to approximately 2 weeks in the peripheral blood and more than 48 days in the lymph node at 25 µg·kg-1 , BID for 8 consecutive days in cynomolgus monkeys. Expansion was observed including monocytes and NK cells. Antibody against the CCR4 immunotoxin was detected after approximately 2 weeks, affecting further depletion efficacy for multiple course treatment.


Subject(s)
Diphtheria Toxin/pharmacology , Immunotoxins/pharmacology , Receptors, CCR4/antagonists & inhibitors , T-Lymphocytes, Regulatory/drug effects , Animals , Diphtheria Toxin/administration & dosage , Immunotoxins/administration & dosage , Macaca fascicularis , Male , Receptors, CCR4/immunology , Recombinant Fusion Proteins/pharmacology , T-Lymphocytes, Regulatory/immunology
2.
Xenotransplantation ; 25(5): e12391, 2018 09.
Article in English | MEDLINE | ID: mdl-29527745

ABSTRACT

BACKGROUND: Despite recent progress in survival times of xenografts in non-human primates, there are no reports of survival beyond 5 days of histologically well-aerated porcine lung grafts in baboons. Here, we report our initial results of pig-to-baboon xeno-lung transplantation (XLTx). METHODS: Eleven baboons received genetically modified porcine left lungs from either GalT-KO alone (n = 3), GalT-KO/humanCD47(hCD47)/hCD55 (n = 3), GalT-KO/hD47/hCD46 (n = 4), or GalT-KO/hCD39/hCD46/hCD55/TBM/EPCR (n = 1) swine. The first 2 XLTx procedures were performed under a non-survival protocol that allowed a 72-hour follow-up of the recipients with general anesthesia, while the remaining 9 underwent a survival protocol with the intention of weaning from ventilation. RESULTS: Lung graft survivals in the 2 non-survival animals were 48 and >72 hours, while survivals in the other 9 were 25 and 28 hours, at 5, 5, 6, 7, >7, 9, and 10 days. One baboon with graft survival >7 days, whose entire lung graft remained well aerated, was euthanized on POD 7 due to malfunction of femoral catheters. hCD47 expression of donor lungs was detected in both alveoli and vessels only in the 3 grafts surviving >7, 9, and 10 days. All other grafts lacked hCD47 expression in endothelial cells and were completely rejected with diffuse hemorrhagic changes and antibody/complement deposition detected in association with early graft loss. CONCLUSIONS: To our knowledge, this is the first evidence of histologically viable porcine lung grafts beyond 7 days in baboons. Our results indicate that GalT-KO pig lungs are highly susceptible to acute humoral rejection and that this may be mitigated by transgenic expression of hCD47.


Subject(s)
Animals, Genetically Modified/immunology , CD47 Antigen/immunology , Graft Rejection/immunology , Graft Survival/immunology , Papio/immunology , Animals , Graft Rejection/pathology , Heterografts/immunology , Humans , Lung/immunology , Lung Transplantation/methods , Swine , Transplantation, Heterologous/methods , Transplants/immunology
SELECTION OF CITATIONS
SEARCH DETAIL